Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Latest EPO Stories

2014-03-28 12:26:15

DUBLIN, March 28, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/8zbxmj/investigation) has announced the addition of the "Investigation Report on China Epoetin Alfa Market, 2009-2018" [http://www.researchandmarkets.com/research/8zbxmj/investigation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Epoetin alfa refers to erythropoietin (EPO), a hormone-like substance secreted by...

2014-03-21 08:22:46

DUBLIN, Mar. 21, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/l5qnzr/guide_to_formal ) has announced the addition of the "Guide To Formal Requirements of the EPO - A Course for Administrative Staff in the Patent Profession (London)" conference to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) The Guide To Formal Requirements of the EPO course will take place on the 27th February 2014 at the Rembrandt Hotel,...

2014-03-11 23:00:21

ChinaMarketResearchReports.com adds Latest Report on “Investigation Report on China Epoetin Alfa Market, 2009-2018” to its store. Dallas, TX (PRWEB) March 12, 2014 Epoetin alfa refers to erythropoietin (EPO), a hormonelike substance secreted by kidney and liver that stimulates erythropoiesis. Indications of EOP approved in China are renal anemia, anemia after chemotherapy and surgery perioperative red blood cell mobilization. The ratio between EPO used in renal dialysis and in...

2014-01-07 13:47:40

In recent years, non-hematopoietic effects of erythropoietin (EPO), via its binding to the EPO receptor in non-hematopoietic tissues, including cancerous tissues, has been reported by many different laboratories worldwide. However, it remains controversial concerning whether EPO, particularly recombinant EPO that is used to treat anemia in patients, may promote cancer cell proliferation and survival. In this paper, the authors show evidence indicating the presence of autocrine/paracrine...

2013-11-07 23:25:14

New product for employers to encourage their workers to use physicians focused on improving care value. Newark, NJ (PRWEB) November 07, 2013 Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ), which has been leading an effort with physicians, hospitals and health care leaders throughout the state to transform how health care is delivered, has developed a new product for employers to encourage employees to use physicians focused on improving the value of care patients receive, rather...

2013-10-16 23:19:46

It’s not the first prediction that has been made about the market for generic forms of biopharmaceutical drugs, but according to Kalorama Information a multi-billion dollar market for biosimilars will arrive in the next five years. The healthcare organization says it’s in almost everyone’s interest - payors, governments, providers and patients seeking low-cost alternatives to the most expensive and effective therapies. New York, NY (PRWEB) October 16, 2013 It’s not the first...

2013-10-11 23:19:29

Protein Engineering Market report categorizes the market for protein engineering by geography, applications, products and technology. http://www.marketsandmarkets.com/Market-Reports/protein-antibody-engineering-market-898.html (PRWEB) October 11, 2013 The report "Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global...

2013-06-10 12:57:45

Researchers at Whitehead Institute have identified a protein that is the target of glucocorticoids, the drugs that are used to increase red blood cell production in patients with certain types of anemia, including those resulting from trauma, sepsis, malaria, kidney dialysis, and chemotherapy. The discovery could spur development of drugs capable of increasing this protein's production without causing the severe side effects associated with glucocorticoids. "This research is medically...

2013-03-20 08:25:34

DALLAS, March 20, 2013 /PRNewswire/ -- The report "Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017", analyses the global protein engineering market by products, technology, applications, and geography with five-year revenue forecasts. It also identifies the factors driving and restraining the...

2012-09-11 06:30:49

AUSTIN, Texas, Sept. 11, 2012 /PRNewswire/ -- Softex, a leading provider of security products and solutions, today announced that it has joined the McAfee Security Innovation Alliance (SIA) partner program. As a member of the McAfee SIA program, Softex will develop a plug-in to the McAfee ePolicy Orchestrator (ePO) management console, which will enable enterprises for the first time to economically disable and manage lost or stolen laptops using the recently announced Softex SecureDisable PC...